A Trial Investigating the Effect of Semaglutide on Hypoglycaemic Counterregulation Compared to Placebo in Subjects With Type 2 Diabetes
Clinical trial NCT02147431 · COMPLETED
Trial details
- NCT number
- NCT02147431
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-21
- Primary completion
- 2015-05-20
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.